Key Highlights
Medicine · Diabetes
This review from Nutrition & Diabetes elucidates the molecular mechanisms driving incretin resistance in Type 2 Diabetes Mellitus (T2DM), moving beyond simple descriptions of hormone deficiency. The researchers detail how desensitization and downregulation of GLP-1 and GIP receptors at the cellular level contribute to the progressive loss of glycemic control. For a clinician managing complex diabetes cases in India, understanding these pathways offers a deeper rationale for optimizing incretin-based therapies and anticipating treatment failure in patients.
Novelty: 78%
Rigor: 85%
Significance: 92%
Validity: 88%
Clarity: 90%
Update Your Briefing Preferences
Stay curious. Stay informed —
Science Briefing
Your briefing is personalized based on your selected fields, keywords, and research interests.
